BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.56M | -12.93M | -21.13M | -23.41M | -13.58M |
| Total Depreciation and Amortization | 58.00K | 37.00K | 47.00K | 38.00K | 49.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.32M | 3.06M | 2.36M | 2.21M | 1.69M |
| Change in Net Operating Assets | -1.79M | -7.53M | 13.58M | 6.23M | -3.94M |
| Cash from Operations | -19.97M | -17.36M | -5.14M | -14.93M | -15.78M |
| Capital Expenditure | -159.00K | -426.00K | -26.00K | -305.00K | -35.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.48M | -77.56M | -- | -- | -- |
| Cash from Investing | -15.64M | -77.99M | -26.00K | -305.00K | -35.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.50M | -1.50M | -1.50M | -1.50M | -1.50M |
| Issuance of Common Stock | -- | -- | 27.65M | 194.18M | 422.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 542.00K | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.24M | -2.54M | -1.31M |
| Cash from Financing | -1.50M | -1.50M | 24.90M | 190.68M | -2.39M |
| Foreign Exchange rate Adjustments | -46.00K | -12.00K | 137.00K | -58.00K | -17.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.16M | -96.86M | 19.88M | 175.39M | -18.22M |